Works by Diaz-Beya, Marina
Results: 33
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Refining the Diagnosis and Prognostic Categorization of Acute Myeloid Leukemia Patients with an Integrated Use of Cytogenetic and Molecular Studies.
- Published in:
- Acta Haematologica, 2013, v. 129, n. 2, p. 65, doi. 10.1159/000343616
- By:
- Publication type:
- Article
Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4033, doi. 10.1007/s00277-024-05923-5
- By:
- Publication type:
- Article
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 10, p. 1695, doi. 10.1007/s00277-014-2100-6
- By:
- Publication type:
- Article
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 12, p. 1233, doi. 10.1007/s00277-010-1019-9
- By:
- Publication type:
- Article
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221127547
- By:
- Publication type:
- Article
Early T‐cell precursor lymphoblastic leukaemia: response to FLAG‐IDA and high‐dose cytarabine with sorafenib after initial refractoriness.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
- By:
- Publication type:
- Article
A Systems Biology- and Machine Learning-Based Study to Unravel Potential Therapeutic Mechanisms of Midostaurin as a Multitarget Therapy on FLT3-Mutated AML.
- Published in:
- BioMedInformatics, 2022, v. 2, n. 3, p. 375, doi. 10.3390/biomedinformatics2030024
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1385987
- By:
- Publication type:
- Article
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 256, doi. 10.1111/bjh.19518
- By:
- Publication type:
- Article
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1529, doi. 10.1111/bjh.19341
- By:
- Publication type:
- Article
Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 892, doi. 10.1111/bjh.19217
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK‐NUP214 shows a favourable outcome when performed in first complete remission.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 920, doi. 10.1111/bjh.16433
- By:
- Publication type:
- Article
Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 6, p. 765, doi. 10.1111/ejh.14291
- By:
- Publication type:
- Article
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8669, doi. 10.3390/ijms25168669
- By:
- Publication type:
- Article
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32306-4
- By:
- Publication type:
- Article
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 3, p. 394, doi. 10.1080/10428194.2023.2295788
- By:
- Publication type:
- Article
A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2394, doi. 10.1080/10428194.2017.1422859
- By:
- Publication type:
- Article
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2383, doi. 10.1080/10428194.2017.1422858
- By:
- Publication type:
- Article
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.
- Published in:
- Cancers, 2024, v. 16, n. 24, p. 4274, doi. 10.3390/cancers16244274
- By:
- Publication type:
- Article
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4028, doi. 10.3390/cancers16234028
- By:
- Publication type:
- Article
Infrequent Presentations of Chronic NPM1 -Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 705, doi. 10.3390/cancers16040705
- By:
- Publication type:
- Article
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3822, doi. 10.3390/cancers15153822
- By:
- Publication type:
- Article
Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4107, doi. 10.3390/cancers14174107
- By:
- Publication type:
- Article
Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199531
- By:
- Publication type:
- Article
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma.
- Published in:
- Cancer Cell International, 2015, v. 15, p. 1, doi. 10.1186/s12935-015-0272-3
- By:
- Publication type:
- Article
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 731, doi. 10.1002/ajh.26519
- By:
- Publication type:
- Article
MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064716
- By:
- Publication type:
- Article
Repositioning of bromocriptine for treatment of acute myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article